Daniëlle Van den Weyngaert

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

Yolande Lievens, Karin Haustermans, Daniëlle Van den Weyngaert et al. · Radiotherapy and Oncology · 1998 · 86 citations

Medicine, Oncology, Radiation Oncology +8

Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control

Daan Nevens, Fréderic Duprez, Jean‐François Daisne et al. · Radiotherapy and Oncology · 2016 · 76 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity

Sandra Nuyts, Maarten Lambrecht, Fréderic Duprez et al. · Radiotherapy and Oncology · 2013 · 70 citations

Medicine, Oncology, Radiation Oncology +16

Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study

Tim Van den Wyngaert, Nils Helsen, Laurens Carp et al. · Journal of Clinical Oncology · 2017 · 64 citations · Full text

Medicine, Oncology, Radiology +16